(114 days)
Not Found
No
The summary describes a standard dental implant system and its components, with no mention of AI or ML capabilities.
Yes
The device is described as an implant that supports restorations like single teeth, bridges, and overdentures, which are used to replace missing teeth and restore oral function. This directly addresses a health condition (tooth loss) and improves the body's structure and function, fitting the definition of a therapeutic device.
No
The provided text describes a dental implant system, which is a device used for supporting dental restorations after osseointegration. It is a therapeutic/restorative device, not a diagnostic one used for identifying or classifying a disease or condition.
No
The device description explicitly states it consists of physical components like threaded dental implants, surgical and laboratory instruments, and prosthetic components, indicating it is a hardware-based medical device system.
Based on the provided information, this device is not an IVD (In Vitro Diagnostic).
Here's why:
- IVD Definition: In vitro diagnostics are tests performed on samples taken from the human body, such as blood, urine, or tissue, to detect diseases, conditions, or infections.
- Device Description: The description clearly states that the XiVE Dental Implant System consists of "subgingival threaded dental implants" and related components for surgical and prosthetic procedures. These are devices that are surgically implanted into the body.
- Intended Use: The intended use is to "support single tooth, bridge and overdenture restorations" after osseointegration. This is a structural and functional purpose within the body, not a diagnostic test performed on a sample outside the body.
The information provided describes a medical device intended for surgical implantation and prosthetic support, which falls under a different regulatory category than in vitro diagnostics.
N/A
Intended Use / Indications for Use
The XiVE Dental Implant System is indicated as follows: Once the implant has osseointegrated, it serves to support single tooth, bridge and overdenture restorations.
Product codes (comma separated list FDA assigned to the subject device)
DZE
Device Description
The XiVE Dental Implant System consists of subgingival threaded dental implants in 3.4 - 5.5mm diameters with 8 - 18mm lengths. The implants are coated with the FRIOS Deep Profile Surface. The XiVE Dental Implant System is comprised of dental implants, surgical and laboratory instruments and prosthetic components. The system is designed for two stage procedures for single tooth replacement and the fixation of bridges and complete dentures.
Mentions image processing
Not Found
Mentions AI, DNN, or ML
Not Found
Input Imaging Modality
Not Found
Anatomical Site
Not Found
Indicated Patient Age Range
Not Found
Intended User / Care Setting
Not Found
Description of the training set, sample size, data source, and annotation protocol
Not Found
Description of the test set, sample size, data source, and annotation protocol
Not Found
Summary of Performance Studies (study type, sample size, AUC, MRMC, standalone performance, key results)
The XiVE dental implant system was tested for compressive and static strength and finite element analysis.
Key Metrics (Sensitivity, Specificity, PPV, NPV, etc.)
Not Found
Predicate Device(s): If the device was cleared using the 510(k) pathway, identify the Predicate Device(s) K/DEN number used to claim substantial equivalence and list them here in a comma separated list exactly as they appear in the text. List the primary predicate first in the list.
Reference Device(s): Identify the Reference Device(s) K/DEN number and list them here in a comma separated list exactly as they appear in the text.
Not Found
Predetermined Change Control Plan (PCCP) - All Relevant Information for the subject device only (e.g. presence / absence, what scope was granted / cleared under the PCCP, any restrictions, etc).
Not Found
§ 872.3640 Endosseous dental implant.
(a)
Identification. An endosseous dental implant is a prescription device made of a material such as titanium or titanium alloy that is intended to be surgically placed in the bone of the upper or lower jaw arches to provide support for prosthetic devices, such as artificial teeth, in order to restore a patient's chewing function.(b)
Classification. (1) Class II (special controls). The device is classified as class II if it is a root-form endosseous dental implant. The root-form endosseous dental implant is characterized by four geometrically distinct types: Basket, screw, solid cylinder, and hollow cylinder. The guidance document entitled “Class II Special Controls Guidance Document: Root-Form Endosseous Dental Implants and Endosseous Dental Implant Abutments” will serve as the special control. (See § 872.1(e) for the availability of this guidance document.)(2)
Classification. Class II (special controls). The device is classified as class II if it is a blade-form endosseous dental implant. The special controls for this device are:(i) The design characteristics of the device must ensure that the geometry and material composition are consistent with the intended use;
(ii) Mechanical performance (fatigue) testing under simulated physiological conditions to demonstrate maximum load (endurance limit) when the device is subjected to compressive and shear loads;
(iii) Corrosion testing under simulated physiological conditions to demonstrate corrosion potential of each metal or alloy, couple potential for an assembled dissimilar metal implant system, and corrosion rate for an assembled dissimilar metal implant system;
(iv) The device must be demonstrated to be biocompatible;
(v) Sterility testing must demonstrate the sterility of the device;
(vi) Performance testing to evaluate the compatibility of the device in a magnetic resonance (MR) environment;
(vii) Labeling must include a clear description of the technological features, how the device should be used in patients, detailed surgical protocol and restoration procedures, relevant precautions and warnings based on the clinical use of the device, and qualifications and training requirements for device users including technicians and clinicians;
(viii) Patient labeling must contain a description of how the device works, how the device is placed, how the patient needs to care for the implant, possible adverse events and how to report any complications; and
(ix) Documented clinical experience must demonstrate safe and effective use and capture any adverse events observed during clinical use.
0
Image /page/0/Picture/1 description: The image shows the logo for the U.S. Department of Health & Human Services. The logo consists of a circular seal with the text "DEPARTMENT OF HEALTH & HUMAN SERVICES - USA" around the perimeter. Inside the circle is a stylized image of an eagle with three lines representing its wings and head. The eagle is facing to the right.
Public Health Service
Food and Drug Administration 9200 Corporate Boulevard Rockville MD 20850
MAR 3 0 2005
FRIADENT GmbH C/O Ms. Carol Patterson Patterson Consulting Group, Incorporated 21911 Erie Lane Lake Forest, California 92630
Re: K013867
Trade/Device Name: Xive Dental Implant System Regulation Number: 21 CFR 872.3640 Regulation Name: Endosseous Dental Implant Regulatory Class: III Product Code: DZE Dated: February 21,2002 Received: February 22,2002
Dear Ms. Patterson:
This letter corrects our substantially equivalent letter of March 15, 2002 regarding the company name.
We have reviewed your Section 510(k) premarket notification of intent to market the device referenced above and have determined the device is substantially equivalent (for the indications for use stated in the enclosure) to legally marketed predicate devices marketed in interstate commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments or to devices that have been reclassified in accordance with the provisions of the Federal Food, Drug, and Cosmetic Act (Act) that do not require approval of a premarket approval (PMA). You may, therefore, market the device, subject to the general controls provisions of the Act. The general controls provisions of the Act include requirements for annual registration, listing of devices, good manufacturing practice, labeling, and prohibitions against misbranding and adulteration.
If your device is classified (see above) into either class II (Special Controls) or class III (PMA), it may be subject to additional controls. Existing major regulations affecting your device can be found in the Code of Federal Regulations, Title 21, Parts 800 to 898. In addition, FDA may publish further announcements concerning your device in the Federal Register.
1
Page 2 - Ms. Patterson
Please be advised that FDA's issuance of a substantial equivalence determination does not mean that FDA has made a determination that your device complies with other requirements of the Act or any Federal statutes and regulations administered by other Federal agencies. You must comply with all the Act's requirements, including, but not limited to: registration and listing (21 CFR Part 807); labeling (21 CFR Part 801); good manufacturing practice requirements as set forth in the quality systems (QS) regulation (21 CFR Part 820); and if applicable, the electronic product radiation control provisions 531-542 of the Act); 21 CFR 1000-1050.
This letter will allow you to continue marketing your device as described in your Section 510(k) premarket notification. The FDA finding of substantial equivalence of your device to a legally marketed predicate device results in a classification for your device and thus, permits your device to proceed to the market.
If you desire specific advice for your device on our labeling regulation (21 CFR Part 801), please contact the Office of Compliance at (240) 276-0115. Also, please note the regulation entitled, "Misbranding by reference to premarket notification" (21CFR Part 807.97). You may obtain other general information on your responsibilities under the Act from the Division of Small Manufacturers, International and Consumer Assistance at its toll-free number (800) 638-2041 or (301) 443-6597 or at its Internet address http:Nwww.fda.gov/cdrh/dsmaldsmamain.html
Sincerely yours.
Suite Michael Oms
Chiu Lin. Ph.D. Director Division of Anesthesiology, General Hospital, Infection Control and Dental Devices Office of Device Evaluation Center for Devices and Radiological Health
Enclosure
2
867
FRIADENT GmbH XiVE Dental Implant System 510(k) Amendment, #K013867, February 5, 2002
INDICATION FOR USE
510(k) Number: K013867 XiVE® Dental Implant System Device Name: The XiVE Dental Implant System is indicated as follows: Indications for Use: Once the implant has osseointegrated, it serves to support single tooth, bridge and overdenture restorations.
(PLEASE DO NOT WRITE BELOW THIS LINE - CONTINUE ON ANOTHER PAGE IF NEEDED)
OR
Concurrence of CDRH, Office of Device Evaluation (ODE)
Prescription Use_ (Per 21 CFR 801.109) Over-The-Counter Use
hrlillra
("Tivision Sign-Off) Control of Dental, Infection Control, ୍ତ General Hospital Devices K1)3862 ್ 100k) Number _
CONFIDENTIAL
3
SUMMARY OF SAFETY AND EFFECTIVENESS SECTION 16:
This 510(k) summary of safety and effectiveness information is being submitted in accordance with the requirements of SMDA 1990 and CFR 807.92.
SUBMITTER INFORMATION 16.1
| a. | Company Name: | FRIADENT GmbH. |
|---|---|---|
| b. | Company Address: | Steinzeugstrasse 50 |
| Mannheim D-68229 | ||
| Germany | ||
| c. | Company Phone: | |
| Company Facsimile: | (011) 49 621 4302 1121 | |
| (011) 49 621 4302 2121 | ||
| d. | Contact Person: | Heike Dietzler |
| Regulatory Affairs Manager | ||
| e. | Date Summary Prepared: | February 21,2002 |
16.2. DEVICE IDENTIFICATION
| a. Trade/Proprietary Name: | XiVE® Dental Implant System |
|---|---|
| b. Classification Name: | Endosseous Dental Implants |
| 21 CFR 872.3640 |
16.3 IDENTIFICATION OF PREDICATE DEVICES
| Company | Device | 510(k) No. | Date Cleared |
|---|---|---|---|
| Nobel BioCare | Branemark System Standard | ||
| 3.75mm Fixture | K925765 | 10105193 | |
| FRIADENT GmbH | FRIALIT-2 Dental Implant | ||
| With Deep Profile Surface | K945847 | 03/15/95 |
4
16.4 DEVICE DESCRIPTION
The XiVE Dental Implant System consists of subgingival threaded dental implants in 3.4 - 5.5mm diameters with 8 - 18mm lengths. The implants are coated with the FRIOS Deep Profile Surface. The XiVE Dental Implant System is comprised of dental implants, surgical and laboratory instruments and prosthetic components. The system is designed for two stage procedures for single twth replacement and the fixation of bridges and complete dentures.
16.5 SUBSTANTIAL EQUIVALENCE
The XiVE® dental implant is substantially equivalent to the current FRIALIT-2® Dental Implant Systems in terms of design, materials, coatings, prosthetic options and intended use. The XIVE® dental implant is substantially equivalent to the Nobel BioCare Branemark 3.75mm dental implant in terms materials, functionality, mechanical strength and intended use.
INTENDED USE 16.6
Once the XiVE Dental Implant has osseointegrated, it serves to support single tooth, bridge and overdenture restorations.
16.7 TECHNOLOGICAL CHARACTERISTICS
The XiVE® dental implant is identical to the current FRIALIT-2® dental implants in terms of coatings, materials and prosthetic options. The XiVE® dental implant is available in 3.4, 3.8, 4.5 and 5.5 mm screw-type implants with FRIOS® Deep Profile Surface. The lengths of the implants range from 8 -18mm. The XiVE dental implants are constructed of CP-2 titanium. A variety of prosthetic options are available for the XiVE system including, MH-6, MH-2, EstheticBase, Cerabase, AuroBase and Protect Abutments, PassivFit, Ball and Socket Attachments. Bar Copings, Round Bar. Bar Clip, and Telescopic
5
Abutments. The XiVE dental implant system was tested for compressive and static strength and finite element analysis.
The XiVE Dental Implant system is equivalent to the Nobel BioCare Branemark Standard Dental Implant System in terms of design, mechanical strength and intended use.
CLASS III CERTIFICATION AND SUMMARY 16.8
This notification contains a Class III certification and summary of adverse safety and effectiveness information pursuant to 513(f) of the Federal Food, Drug, and Cosmetic Act.
16.9 CONCLUSIONS
This notification contains all information required by 21 CFR 807.87. A completed copy of the Premarket Notification 510(k) Reviewer's Checklist is provided in this submission. Performance evaluations of the XiVE dental implant system show that the device performs as intended. Comparison the XiVE dental implant system to the predicate devices, show that the device is substantially equivalent.